Home

Moderna, Inc. - Common Stock (MRNA)

34.94
+0.77 (2.25%)

Moderna Inc is a biotechnology company focused on developing innovative messenger RNA (mRNA) therapeutics and vaccines for a wide array of diseases

Utilizing its proprietary mRNA technology platform, Moderna aims to harness the body's own cellular machinery to produce proteins that can help prevent or treat illnesses, including infectious diseases, cancer, and rare genetic disorders. The company gained significant attention for its development of an effective COVID-19 vaccine, but its pipeline also includes various other candidates in different stages of clinical development aimed at addressing unmet medical needs. Through its research and development efforts, Moderna seeks to transform the field of medicine and improve patient outcomes globally.

SummaryNewsPress ReleasesChartHistoricalFAQ
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · February 4, 2025
RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.investors.com
RFK Jr. cleared a key hurdle Tuesday after the Senate Finance Committee voted along party lines in favor of his nomination.
Via Investor's Business Daily · February 4, 2025
Robert F. Kennedy's Health Secretary Nomination Advances To Full Senate: Vaccine Stocks Dropbenzinga.com
The U.S. Senate Finance Committee on Tuesday voted 14 to 13 in favor of advancing the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Via Benzinga · February 4, 2025
This Is What Whales Are Betting On Modernabenzinga.com
Via Benzinga · February 4, 2025
Exploring the top movers within the S&P500 index during today's session.chartmill.com
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday.
Via Chartmill · February 3, 2025
Decoding Moderna's Options Activity: What's the Big Picture?benzinga.com
Via Benzinga · January 29, 2025
How Is The Market Feeling About Moderna?benzinga.com
Via Benzinga · January 28, 2025
Top S&P500 movers in Monday's sessionchartmill.com
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · February 3, 2025
4 Top Stocks to Buy in Februaryfool.com
Here are four stocks to buy now that could offer investors upside in the short and long terms.
Via The Motley Fool · February 1, 2025
Wednesday's session: top gainers and losers in the S&P500 indexchartmill.com
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday.
Via Chartmill · January 29, 2025
Wednesday's pre-market session: top gainers and losers in the S&P500 indexchartmill.com
Pre-market stock analysis of S&P500 stocks on 2025-01-29: top gainers and losers in today's session.
Via Chartmill · January 29, 2025
3 Things You Need to Know if You Buy Moderna Todayfool.com
Via The Motley Fool · January 25, 2025
The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearingsinvestors.com
The Senate will meet Wednesday to start the confirmation hearing process for Robert F. Kennedy Jr.
Via Investor's Business Daily · January 29, 2025
Moderna Stock Is Sliding Wednesday: Here's Whybenzinga.com
Moderna Inc (NASDAQMRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need to know.
Via Benzinga · January 29, 2025
Robert Kennedy Jr. Faces Senate Confirmation Hearings As Bird Flu Concerns Grow: Caroline Kennedy Says Cousin 'Predator' Unfit For Officebenzinga.com
Robert F. Kennedy, Jr. will begin Senate confirmation hearings on Wednesday as President Donald Trump's pick to lead the Department of Health and Human Services.
Via Benzinga · January 29, 2025
This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesdaybenzinga.com
Via Benzinga · January 29, 2025
Top S&P500 movers in Tuesday's sessionchartmill.com
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
Via Chartmill · January 28, 2025
3 ETFs Shine As Trump's First Week Sparks Record Gains Followed By Tech Slumpbenzinga.com
The S&P 500 had a strong first week, with ETFs such as SPY, VOO and IVV seeing gains. Were Trump's economic policies a factor?
Via Benzinga · January 28, 2025
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?benzinga.com
The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health Organization on Monday, marking a dramatic acceleration of President Donald Trump's executive order to withdraw from the global health body.
Via Benzinga · January 28, 2025
ETFs Shine As S&P 500 Hits Record High: Top 5 ETFs With Best Gains From Last Weekbenzinga.com
Global economy and financial markets saw a lot of activity in Jan. 24 week. S&P 500 reached record high, several ETFs had double-digit gains.
Via Benzinga · January 27, 2025
10 Worst Performing Large-Caps Last 12 Monthstalkmarkets.com
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.
Via Talk Markets · January 27, 2025
Why Moderna Stock Jumped Over 20% This Weekfool.com
Are you ready for artificial intelligence (AI)-driven mRNA vaccines?
Via The Motley Fool · January 25, 2025
Netflix, Palantir And Moderna Are Among Top 12 Large Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio?benzinga.com
12 large-cap stocks saw significant gains last week, including Summit Therapeutics, Rocket Lab, Moderna, and Netflix. Analysts raised price forecasts.
Via Benzinga · January 26, 2025
3 Beaten-Down Stocks That Haven't Been This Cheap in More Than 3 Years: Are They Bargain Buys?fool.com
Via The Motley Fool · January 25, 2025
Moderna Retains Retail Support With European COVID-19 Vaccine Tender Win, Stock Hits 2-Week Highstocktwits.com
The agreement, which spans up to four years, allows 17 participating countries access to Moderna’s vaccine in various formats.
Via Stocktwits · January 24, 2025